Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | IDH1 | O75874 | 10/20 | 0.43 |
| ▸ | PIM1 | P11309 | 1/20 | 0.42 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.42 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6178399 | 0.96 | EPHX2 (0.43) | EPHX2IDH1PIM1PIM3PIM2 | |
| SCHEMBL6176160 | 0.95 | IDH1 (0.45) | EPHX2IDH1PIM1PIM3PIM2 | |
| SCHEMBL6176634 | 0.89 | EPHX2 (0.46) | EPHX2PIM1PIM3PIM2GAA | |
| SCHEMBL6176374 | 0.88 | EPHX2 (0.46) | EPHX2PIM1PIM3PIM2GAA | |
| SCHEMBL6175654 | 0.88 | EPHX2 (0.46) | EPHX2PIM1PIM3PIM2GAA | |
| SCHEMBL15799246 | 0.87 | EPHX2 (0.45) | EPHX2PIM1PIM3PIM2GAA | |
| SCHEMBL6177544 | 0.86 | EPHX2 (0.44) | EPHX2PIM1PIM3PIM2GAA | |
| SCHEMBL6179436 | 0.86 | HTT (0.48) | EPHX2PIM1PIM3PIM2GAA | |
| SCHEMBL6177724 | 0.86 | EPHX2 (0.44) | EPHX2PIM1PIM3PIM2GAA | |
| SCHEMBL6179544 | 0.85 | CASP3 (0.49) | EPHX2PIM1PIM3PIM2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0945445-B9 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-0945445-B1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |
| EP-0945445-A1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |